These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 11078768)
1. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group. Brill-Edwards P; Ginsberg JS; Gent M; Hirsh J; Burrows R; Kearon C; Geerts W; Kovacs M; Weitz JI; Robinson KS; Whittom R; Couture G; N Engl J Med; 2000 Nov; 343(20):1439-44. PubMed ID: 11078768 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253 [TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry. Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M; Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945 [TBL] [Abstract][Full Text] [Related]
4. The incidence and risk factors of recurrent venous thromboembolism during pregnancy. Galambosi PJ; Ulander VM; Kaaja RJ Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671 [TBL] [Abstract][Full Text] [Related]
5. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study. Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925 [TBL] [Abstract][Full Text] [Related]
6. Sex and gender issues and venous thromboembolism. Moores L; Bilello KL; Murin S Clin Chest Med; 2004 Jun; 25(2):281-97. PubMed ID: 15099889 [TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. Lee AY; Levine MN; Baker RI; Bowden C; Kakkar AK; Prins M; Rickles FR; Julian JA; Haley S; Kovacs MJ; Gent M; N Engl J Med; 2003 Jul; 349(2):146-53. PubMed ID: 12853587 [TBL] [Abstract][Full Text] [Related]
8. Prediction, prevention, and treatment of venous thromboembolic disease in pregnancy. Zotz RB; Gerhardt A; Scharf RE Semin Thromb Hemost; 2003 Apr; 29(2):143-54. PubMed ID: 12709917 [TBL] [Abstract][Full Text] [Related]
9. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. Kearon C; Gent M; Hirsh J; Weitz J; Kovacs MJ; Anderson DR; Turpie AG; Green D; Ginsberg JS; Wells P; MacKinnon B; Julian JA N Engl J Med; 1999 Mar; 340(12):901-7. PubMed ID: 10089183 [TBL] [Abstract][Full Text] [Related]
10. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. Schulman S; Granqvist S; Holmström M; Carlsson A; Lindmarker P; Nicol P; Eklund SG; Nordlander S; Lärfars G; Leijd B; Linder O; Loogna E N Engl J Med; 1997 Feb; 336(6):393-8. PubMed ID: 9010144 [TBL] [Abstract][Full Text] [Related]
11. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB; Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714 [TBL] [Abstract][Full Text] [Related]
12. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. Schulman S; Lindmarker P N Engl J Med; 2000 Jun; 342(26):1953-8. PubMed ID: 10874063 [TBL] [Abstract][Full Text] [Related]
13. Electronic alerts to prevent venous thromboembolism among hospitalized patients. Kucher N; Koo S; Quiroz R; Cooper JM; Paterno MD; Soukonnikov B; Goldhaber SZ N Engl J Med; 2005 Mar; 352(10):969-77. PubMed ID: 15758007 [TBL] [Abstract][Full Text] [Related]
14. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism. Simioni P; Tormene D; Prandoni P; Girolami A Thromb Haemost; 2001 Sep; 86(3):929. PubMed ID: 11583329 [No Abstract] [Full Text] [Related]
16. The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Kher A; Bauersachs R; Nielsen JD Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011 [TBL] [Abstract][Full Text] [Related]
17. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390 [TBL] [Abstract][Full Text] [Related]
18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
19. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. James AH; Brancazio LR; Ortel TL Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990 [TBL] [Abstract][Full Text] [Related]
20. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV; N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]